Factors associated with the quality of life of Korean COPD patients as measured by the EQ-5D

Quality of Life Research

Volumn 24, Issue 10, 2015, Pages 2549-2558

  Hong, Ji Young ^a   Kim, Song Yee ^a   Chung, Kyung Soo ^a   Kim, Eun Young ^a   Jung, Ji Ye ^a   Park, Moo Suk ^a   Kang, Young Ae ^a   Kim, Se Kyu ^a   Chang, Joon ^a   Kim, Young Sam ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Chronic obstructive lung disease; Health surveys; Korea; Quality of life; Spirometry

Indexed keywords

ADULT; AGE; AIRWAY OBSTRUCTION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EVALUATION; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EDUCATIONAL STATUS; EUROQOL FIVE DIMENSION QUESTIONNAIRE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENDER; HOUSEHOLD; HOUSEHOLD INCOME; HUMAN; INCOME; KOREAN (PEOPLE); MAJOR CLINICAL STUDY; MALE; QUALITY OF LIFE; QUALITY OF LIFE ASSESSMENT; SPIROMETRY; VISUAL ANALOG SCALE; AGED; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRE; SOUTH KOREA;

ADULT; AGED; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; REPUBLIC OF KOREA; SURVEYS AND QUESTIONNAIRES;

EID: 84941414780     PISSN: 09629343     EISSN: 15732649     Source Type: Journal    
DOI: 10.1007/s11136-015-0979-6     Document Type: Article

References (36)

1. Rabe, K. F., Hurd, S., Anzueto, A., Barnes, P. J., Buist, S. A., Calverley, P., et al. (2007). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease—GOLD executive summary. American Journal of Respiratory and Critical Care Medicine,176(6), 532–555.
2. Decramer, M., Sibille, Y., Bush, A., Carlsen, K. H., Rabe, K. F., Clancy, L., et al. (2011). The European Union conference on chronic respiratory disease: Purpose and conclusions. European Respiratory Journal,37(4), 738–742.
3. Vestbo, J., Hurd, S. S., Agusti, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., et al. (2013). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. American Journal of Respiratory and Critical Care Medicine,187(4), 347–365.
4. Decramer, M., Celli, B., Kesten, S., Lystig, T., Mehra, S., & Tashkin, D. P. (2009). Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): A prespecified subgroup analysis of a randomised controlled trial. Lancet,374(9696), 1171–1178.
5. Jenkins, C. R., Jones, P. W., Calverley, P. M., Celli, B., Anderson, J. A., Ferguson, G. T., et al. (2009). Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: Analysis from the randomised, placebo-controlled TORCH study. Respiratory Research,10, 59.
6. Jones, P. W. (2009). Health status and the spiral of decline. COPD,6(1), 59–63.
7. Guyatt, G. H., Feeny, D. H., & Patrick, D. L. (1993). Measuring health-related quality of life. Annals of Internal Medicine,118(8), 622–629.
8. Carrasco Garrido, P., de Miguel Diez, J., Rejas Gutierrez, J., Centeno, A. M., Gobartt Vazquez, E., Gil de Miguel, A., et al. (2006). Negative impact of chronic obstructive pulmonary disease on the health-related quality of life of patients. Results of the EPIDEPOC study. Health and Quality of Life Outcomes,4, 31.
9. Rutten-van, M. P. M., Oostenbrink, J. B., Tashkin, D. P., Burkhart, D., & Monz, B. U. (2006). Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages? Chest,130(4), 1117–1128.
10. Ferrer, M., Alonso, J., Morera, J., Marrades, R. M., Khalaf, A., Aguar, M. C., et al. (1997). Chronic obstructive pulmonary disease stage and health-related quality of life. The quality of life of chronic obstructive pulmonary disease study group. Annals of Internal Medicine,127(12), 1072–1079.
11. DiBonaventura, M., Paulose-Ram, R., Su, J., McDonald, M., Zou, K. H., Wagner, J. S., et al. (2012). The impact of COPD on quality of life, productivity loss, and resource use among the elderly United States workforce. COPD,9(1), 46–57.
12. Burgel, P. R., Escamilla, R., Perez, T., Carre, P., Caillaud, D., Chanez, P., et al. (2013). Impact of comorbidities on COPD-specific health-related quality of life. Respiratory Medicine,107(2), 233–241.
13. Weldam, S. W., Lammers, J. W., Decates, R. L., & Schuurmans, M. J. (2013). Daily activities and health-related quality of life in patients with chronic obstructive pulmonary disease: Psychological determinants: A cross-sectional study. Health and Quality of Life Outcomes,11, 190.
14. Popa-Velea, O., & Purcarea, V. (2014). Psychological factors mediating health-related quality of life in COPD. Journal of Medicine and Life,7(1), 100–103.
15. Yoo, K. H., Kim, Y. S., Sheen, S. S., Park, J. H., Hwang, Y. I., Kim, S. H., et al. (2011). Prevalence of chronic obstructive pulmonary disease in Korea: The fourth Korean National Health and Nutrition Examination Survey, 2008. Respirology,16(4), 659–665.
16. Kim, S. H., Oh, Y. M., & Jo, M. W. (2014). Health-related quality of life in chronic obstructive pulmonary disease patients in Korea. Health and Quality of Life Outcomes,12, 57.
17. Miller, M. R., Hankinson, J., Brusasco, V., Burgos, F., Casaburi, R., Coates, A., et al. (2007). Standardisation of spirometry. Revue des Maladies Respiratoires,24(3), S27–S49.
18. Rabin, R., & de Charro, F. (2001). EQ-5D: A measure of health status from the EuroQol Group. Annals of Medicine,33(5), 337–343.
19. Brooks, R. (1996). EuroQol: The current state of play. Health Policy,37(1), 53–72.
20. group E. (1990). EuroQol–a new facility for the measurement of health-related quality of life. Health Policy,16(3), 199–208.
21. Lee, Y. K., Nam, H. S., Chuang, L. H., Kim, K. Y., Yang, H. K., Kwon, I. S., et al. (2009). South Korean time trade-off values for EQ-5D health states: Modeling with observed values for 101 health states. Value in Health,12(8), 1187–1193.
22. Pickard, A. S., Yang, Y., & Lee, T. A. (2011). Comparison of health-related quality of life measures in chronic obstructive pulmonary disease. Health and Quality of Life Outcomes,9, 26.
23. Jones, P. W., Quirk, F. H., Baveystock, C. M. (1991). The St George’s Respiratory Questionnaire. Respir Med, 85 Suppl B, 25–31; discussion 33–27.
24. Glasziou, P., Alexander, J., Beller, E., & Clarke, P. (2007). Which health-related quality of life score? A comparison of alternative utility measures in patients with Type 2 diabetes in the ADVANCE trial. Health and Quality of Life Outcomes,5, 21.
25. Punekar, Y. S., Rodriguez-Roisin, R., Sculpher, M., Jones, P., & Spencer, M. (2007). Implications of chronic obstructive pulmonary disease (COPD) on patients’ health status: A western view. Respiratory Medicine,101(3), 661–669.
26. Antonelli-Incalzi, R., Imperiale, C., Bellia, V., Catalano, F., Scichilone, N., Pistelli, R., et al. (2003). Do GOLD stages of COPD severity really correspond to differences in health status? European Respiratory Journal,22(3), 444–449.
27. Yeo, J., Karimova, G., & Bansal, S. (2006). Co-morbidity in older patients with COPD—its impact on health service utilisation and quality of life, a community study. Age and Ageing,35(1), 33–37.
28. Ketelaars, C. A., Schlosser, M. A., Mostert, R., Huyer Abu-Saad, H., Halfens, R. J., & Wouters, E. F. (1996). Determinants of health-related quality of life in patients with chronic obstructive pulmonary disease. Thorax,51(1), 39–43.
29. Carrasco-Garrido, P., de Miguel-Diez, J., Rejas-Gutierrez, J., Martin-Centeno, A., Gobartt-Vazquez, E., Hernandez-Barrera, V., et al. (2009). Characteristics of chronic obstructive pulmonary disease in Spain from a gender perspective. BMC Pulmonary Medicine,9, 2.
30. Naberan, K., Azpeitia, A., Cantoni, J., & Miravitlles, M. (2012). Impairment of quality of life in women with chronic obstructive pulmonary disease. Respiratory Medicine,106(3), 367–373.
31. Miravitlles, M., Naberan, K., Cantoni, J., & Azpeitia, A. (2011). Socioeconomic status and health-related quality of life of patients with chronic obstructive pulmonary disease. Respiration,82(5), 402–408.
32. Johannessen, A., Eagan, T. M., Omenaas, E. R., Bakke, P. S., & Gulsvik, A. (2010). Socioeconomic risk factors for lung function decline in a general population. European Respiratory Journal,36(3), 480–487.
33. Tsukino, M., Nishimura, K., Ikeda, A., Koyama, H., Mishima, M., & Izumi, T. (1996). Physiologic factors that determine the health-related quality of life in patients with COPD. Chest,110(4), 896–903.
34. Stahl, E., Lindberg, A., Jansson, S. A., Ronmark, E., Svensson, K., Andersson, F., et al. (2005). Health-related quality of life is related to COPD disease severity. Health and Quality of Life Outcomes,3, 56.
35. Jackson, B. E., Coultas, D. B., Suzuki, S., Singh, K. P., & Bae, S. (2013). Rural-urban disparities in quality of life among patients with COPD. The Journal of Rural Health,29(Suppl 1), s62–s69.
36. Wilke, S., Janssen, D. J., Wouters, E. F., Schols, J. M., Franssen, F. M., & Spruit, M. A. (2012). Correlations between disease-specific and generic health status questionnaires in patients with advanced COPD: A one-year observational study. Health and Quality of Life Outcomes,10, 98.